Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
One quarter of the global population is estimated to have nonalcoholic fatty liver disease
(NAFLD). The incidence of nonalcoholic steatohepatitis (NASH) is projected to increase by …
(NAFLD). The incidence of nonalcoholic steatohepatitis (NASH) is projected to increase by …
NAFLD‐related hepatocellular carcinoma: The growing challenge
PA Shah, R Patil, SA Harrison - Hepatology, 2023 - journals.lww.com
Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and
morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the …
morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the …
The hallmarks of ferroptosis
SJ Dixon, BR Stockwell - Annual review of cancer biology, 2019 - annualreviews.org
Ferroptosis is a nonapoptotic, iron-dependent form of cell death that can be activated in
cancer cells by natural stimuli and synthetic agents. Three essential hallmarks define …
cancer cells by natural stimuli and synthetic agents. Three essential hallmarks define …
Acetyl coenzyme A: a central metabolite and second messenger
Acetyl-coenzyme A (acetyl-CoA) is a central metabolic intermediate. The abundance of
acetyl-CoA in distinct subcellular compartments reflects the general energetic state of the …
acetyl-CoA in distinct subcellular compartments reflects the general energetic state of the …
The interplay between cell signalling and the mevalonate pathway in cancer
The mevalonate (MVA) pathway is an essential metabolic pathway that uses acetyl-CoA to
produce sterols and isoprenoids that are integral to tumour growth and progression. In …
produce sterols and isoprenoids that are integral to tumour growth and progression. In …
Metabolic control of YAP and TAZ by the mevalonate pathway
G Sorrentino, N Ruggeri, V Specchia… - Nature cell …, 2014 - nature.com
The YAP and TAZ mediators of the Hippo pathway (hereafter called YAP/TAZ) promote
tissue proliferation and organ growth. However, how their biological properties intersect with …
tissue proliferation and organ growth. However, how their biological properties intersect with …
[HTML][HTML] Statin use and reduced cancer-related mortality
SF Nielsen, BG Nordestgaard… - New England Journal of …, 2012 - Mass Medical Soc
Background A reduction in the availability of cholesterol may limit the cellular proliferation
required for cancer growth and metastasis. We tested the hypothesis that statin use begun …
required for cancer growth and metastasis. We tested the hypothesis that statin use begun …
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention
A Albini, G Pennesi, F Donatelli… - Journal of the …, 2010 - academic.oup.com
Due to the aging of the populations of developed countries and a common occurrence of risk
factors, it is increasingly probable that a patient may have both cancer and cardiovascular …
factors, it is increasingly probable that a patient may have both cancer and cardiovascular …
The mevalonate pathway, a metabolic target in cancer therapy
B Guerra, C Recio, H Aranda-Tavío… - Frontiers in …, 2021 - frontiersin.org
A hallmark of cancer cells includes a metabolic reprograming that provides energy, the
essential building blocks, and signaling required to maintain survival, rapid growth …
essential building blocks, and signaling required to maintain survival, rapid growth …
Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis
BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is a leading cause of cancer-
related mortality worldwide. Several studies have shown that statins could have …
related mortality worldwide. Several studies have shown that statins could have …